Can you take ACE-031 and Sermorelin together?

There is no specific, well-documented interaction rule for combining ACE-031 and Sermorelin in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, ACE-031 or Sermorelin?

ACE-031 is currently investigational (in trials) and Sermorelin is fda-approved. "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

ACE-031 vs Sermorelin

Q: What is the difference between ACE-031 and Sermorelin?

ACE-031: Soluble form of activin type IIB receptor (ActRIIB-Fc fusion protein) that acts as a myostatin and activin trap. Blocks the primary signals that limit muscle growth by sequestering myostatin, activin, and related ligands before they reach cell surface receptors. Phase 2 trials in Duchenne muscular dystrophy demonstrated significant lean mass increases. Sermorelin: Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

ACE-031

Investigational (in trials)

Soluble form of activin type IIB receptor (ActRIIB-Fc fusion protein) that acts as a myostatin and activin trap. Blocks the primary signals that limit muscle growth by sequestering myostatin, activin, and related ligands before they reach cell surface receptors. Phase 2 trials in Duchenne muscular dystrophy demonstrated significant lean mass increases.

Full profile

Sermorelin

FDA-approved

Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH.

Full profile

	ACE-031	Sermorelin
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	ACVR2B-Fc, ActRIIB-Fc fusion protein	GHRH 1-29, GRF 1-29 NH2, Geref
Evidence	Investigational (in trials)	FDA-approved
Dosing range	0.3mg/kg–3mg/kg mg/kg, every 2–4 weeks (subcutaneous injection)	100mcg–500mcg mcg, once daily (before sleep)
Administration	Subcutaneous injection	Subcutaneous injection
Key side effects	Nosebleeds (epistaxis — most common reported AE), Telangiectasia (visible small blood vessel dilation), Gum bleeding, Elevated hemoglobin	Injection site redness, Headache, Flushing, Dizziness
Cited sources	2 references	1 reference

Key differences

Evidence level differs: ACE-031 is investigational (in trials), while Sermorelin is fda-approved.
Dosing units differ: ACE-031 is dosed in mg/kg, Sermorelin in mcg — they operate at different scales.
Frequency: ACE-031 is typically every 2–4 weeks (subcutaneous injection); Sermorelin is once daily (before sleep).
Research depth: this profile cites 2 sources for ACE-031 vs 1 for Sermorelin.

How each works

ACE-031

ACE-031 functions as a decoy receptor, binding myostatin, activin A/B, GDF-11, and BMP-9 in circulation before they can activate cellular ActRIIB receptors. In the Duchenne muscular dystrophy Phase 2 trial, ACE-031 produced meaningful lean body mass increases but was halted due to vascular side effects (epistaxis, telangiectasia) requiring dose and safety optimization.

Sermorelin

Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.

Read the full ACE-031 profile Read the full Sermorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.